title: Trastuzumab-associated peripheral vascular toxicity.
authors.affiliation: British Columbia Cancer Agency, Fraser Valley Centre, Surrey, British Columbia, Canada.
authors.forename: Gary K
authors.initials: GK
authors.lastname: Pansegrau
authors.forename: Dennis R
authors.initials: DR
authors.lastname: Grant
authors.forename: Brian
authors.initials: B
authors.lastname: Norris
authors.forename: Karen A
authors.initials: KA
authors.lastname: Gelmon
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001132:Arm / Q000098:blood supply; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D000068878:Trastuzumab; D014652:Vascular Diseases / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015251:Epirubicin; D003520:Cyclophosphamide; D000068878:Trastuzumab; D005472:Fluorouracil